Point72 Hong Kong Ltd - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 168 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.

Quarter-by-quarter ownership
Point72 Hong Kong Ltd ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$61,000
-63.0%
1,097
-51.7%
0.00%
-66.7%
Q1 2022$165,000
+42.2%
2,270
+162.1%
0.01%
+50.0%
Q3 2021$116,000
+33.3%
866
-80.2%
0.00%
-55.6%
Q3 2020$87,000
+1640.0%
4,371
+1518.9%
0.01%
+350.0%
Q1 2019$5,000
+400.0%
270
+250.6%
0.00%
Q4 2018$1,000
-98.3%
77
-96.3%
0.00%
-100.0%
Q3 2018$60,000
+757.1%
2,083
+739.9%
0.02%
+950.0%
Q2 2018$7,000
-89.2%
248
-91.9%
0.00%
-94.1%
Q1 2018$65,0003,0650.03%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,113,376$89,359,00015.01%
Burrage Capital Management LLC 63,634$5,107,0004.14%
Integral Health Asset Management, LLC 170,000$13,643,0003.90%
Ally Bridge Group (NY) LLC 225,000$18,057,0003.46%
Elmwood Wealth Management, Inc. 67,174$5,391,0003.29%
Nikko Asset Management Americas, Inc. 4,843,270$388,697,0001.90%
ARK Investment Management 9,611,911$771,404,0001.53%
Spectrum Planning & Advisory Services Inc. 18,521$1,486,0001.53%
Lombard Odier Asset Management (Switzerland) SA 282,953$22,708,0001.51%
Intellectus Partners, LLC 71,625$4,606,0001.26%
View complete list of INTELLIA THERAPEUTICS INC shareholders